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ABSTRACT
The amino acid selenocysteine is encoded by UGA, usually a stop codon, thus requiring a specialized machinery to enable its
incorporation into selenoproteins. The machinery comprises the tRNASec, a 3′-UTR mRNA stem–loop termed SElenoCysteine
Insertion Sequence (SECIS), which is mandatory for recoding UGA as a Sec codon, the SECIS Binding Protein 2 (SBP2), and
other proteins. Little is known about the molecular mechanism and, in particular, when, where, and how the SECIS and SBP2
contact the ribosome. Previous work by others used the isolated SECIS RNA to address this question. Here, we developed a
novel approach using instead engineered minimal selenoprotein mRNAs containing SECIS elements derivatized with
photoreactive groups. By cross-linking experiments in rabbit reticulocyte lysate, new information could be gained about the
SBP2 and SECIS contacts with components of the translation machinery at various translation steps. In particular, we found
that SBP2 was bound only to the SECIS in 48S pre-initiation and 80S pretranslocation complexes. In the complex where the
Sec-tRNASec was accommodated to the A site but transpeptidation was blocked, SBP2 bound the ribosome and possibly the
SECIS element as well, and the SECIS had flexible contacts with the 60S ribosomal subunit involving several ribosomal
proteins. Altogether, our findings led to broadening our understanding about the unique mechanism of selenocysteine
incorporation in mammals.
Keywords: mammalian ribosome; cross-linking approach; selenocysteine incorporation; selenocysteine insertion sequence;
SECIS-binding protein 2
INTRODUCTION
Selenium is an essential micronutrient that exerts significant
health benefits. Implicated in the prevention of cancer and
male infertility, it has also been shown as an important fac-
tor for thyroid hormone maturation, the immune system,
and muscle development and function (Papp et al. 2007;
Lescure et al. 2009). The main biological form of selenium
is the amino acid selenocysteine (Sec) (Zhang and Gladyshev
2011). Selenocysteine-containing proteins are found in the
three domains of life, albeit not in all species. Selenocysteine
is encoded by a UGA triplet that is generally recognized as a
stop codon (Chambers et al. 1986). A specialized mechanism
is, therefore, required to cotranslationally incorporate this
amino acid into the nascent polypeptide chain. The mecha-
nism has been decrypted in detail in bacteria (Böck et al.
2006). However, only the key players and not the mechanism
have been identified so far in eukaryotes (Allmang et al.
2009). First, a 3′-UTR-located mRNA stem–loop called
SECIS (SElenoCysteine Insertion Sequence) is mandatory
for selenoprotein synthesis. Second, decoding of UGA Sec re-
quires the specialized elongation factor eEFSec that delivers
the Sec-tRNASec to the ribosomal A site (Fagegaltier et al.
2000a; Tujebajeva et al. 2000; Gonzalez-Flores et al. 2012)
and the SECIS binding protein 2 (SBP2) that interacts with
eEFSec, the SECIS, and the ribosome (Copeland et al.
2000, 2001; Caban et al. 2007; Takeuchi et al. 2009; Gonza-
lez-Flores et al. 2012). SBP2 was characterized in rat, humans,
and Drosophila (Copeland et al. 2000; Lescure et al. 2002;
Takeuchi et al. 2009). The mammalian SBP2 is ∼850 aa
long and contains two domains. The C-terminal domain is
necessary for interaction with the ribosome (Copeland
et al. 2001; Caban et al. 2007; Takeuchi et al. 2009) and
also contains two modules important for SECIS binding.
The first module, called L7Ae, is shared by ribosomal pro-
teins L7Ae and L30 and several core proteins of sn- and
snoRNPs (Allmang et al. 2002). The second module, called
either the bipartite RNA binding domain (Bubenik and
Driscoll 2007) or selenocysteine insertion domain (SID)
(Donovan et al. 2008) or K-rich domain (Takeuchi et al.
2009), contains a conserved lysine-rich motif. The L7Ae
module and an adjacent region were also predicted to con-
tribute to the SBP2-ribosome interaction (Copeland et al.
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2001; Caban et al. 2007). The SBP2 N-terminal domain is
dispensable for selenoprotein synthesis in reticulocyte lysate
(Copeland et al. 2000) and its function is still unknown.
Regarding binding of SBP2 to the ribosome, we showed it
to bind exclusively the human 60S but not the 40S ribosomal
subunit in vitro (Takeuchi et al. 2009). Recently, ribosome-
bound SBP2 was shown to increase the reactivity to acylation
of the ribose 2′ OH at specific residues of the 28S rRNA locat-
ed near the peptidyl-transferase center and E site, respectively
(Caban and Copeland 2012).
Two different models for selenoprotein synthesis in eu-
karyotes have been proposed so far (Chavatte et al. 2005;
Donovan et al. 2008). They converge on one aspect concern-
ing delivery of the eEFSec•Sec-tRNASec•GTP complex to the
ribosome in the course of selenoprotein mRNA translation.
According to these models, when the ribosome pauses at
the UGA Sec codon, the SECIS-bound SBP2 serves as a plat-
form to recruit the eEFSec•Sec-tRNASec•GTP complex to the
ribosome.
However, the detailedmechanism of selenoprotein synthe-
sis is still missing. In an attempt to bring some mechanistic
insight, the work described here focuses on different transla-
tional steps. To this end, we developed a new approach using
selenoprotein mRNAs instead of the isolated SECIS as in
previous studies by others. Minimal selenoprotein mRNAs
bearing a SECIS element with photoreactive groups were en-
gineered and used for cross-linking to ribosomes in rabbit re-
ticulocyte lysate. Cross-linking experiments combined with
Western blotting led us to localize SBP2 during various steps
of translation. The data allowed us to propose new insights
into the mechanism of selenocysteine insertion.
RESULTS
Design and synthesis of minimal selenoprotein mRNAs
For studying the mechanism of selenoprotein synthesis
in mammals, we decided to use minimal selenoprotein
mRNA containing an m7G cap, a 5′ UTR, a short open read-
ing frame, and a 3′ UTR with the SECIS element (Fig. 1A).
Full-length minimal mRNA was assembled by splint-aided
T4 DNA ligation of two RNA segments (5′ Sec RNA or 5′
Phe RNA, and SECIS in Fig. 1A). The
minimal mRNA contained a short 5′
UTR, which is A-rich to minimize sec-
ondary structure formation and self-
association of mRNA (Bulygin et al.
2005), followed by (1) the AUGUGA
UUCUUC sequence encoding the tetra-
peptideMet-Sec-Phe-Phe, (2) a UAA ter-
mination codon, and (3) the SECIS
element of the rat glutathione peroxidase
1 (GPx1) selenoprotein mRNA in the 3′
UTR (Walczak et al. 1998). The crucial
parameters considered for the design of
the minimal mRNA were the distances
between the Sec codon and the SECIS el-
ement and between the Sec and the stop
codons. In order to mimic as much as
possible a genuine selenoprotein mRNA,
the distances were chosen to most re-
semble those existing in the selenopro-
tein O mRNA (Castellano et al. 2008).
In addition, as they are rather short,
they facilitate DNA template synthesis.
Sec was substituted for Phe in the control
mRNA. The final mRNAs obtained were
designated as flSec mRNA (full-length
mRNA, containing the Sec codon) and
flPhe mRNA (full-length mRNA, where
Sec was replaced by a Phe codon), respec-
tively (Fig. 1A). A mutant flSec mRNA
(Mut1 mRNA), which contained four
Watson-Crick base pairs in the central
core of the SECIS instead of the four
non-Watson-Crick base pairs (Walczak
FIGURE 1. Schematic representation of the minimal mRNAs and their photoreactive derivatives
used in this work. (A) Minimal mRNAs with WT GPx1 SECIS: flSec mRNA, mRNA carrying
UGA Sec codon, and flPhe mRNA, mRNA carrying a Phe codon instead of UGA. SECIS-element
of Mut1 mRNA contains nucleotide residues shown in the box instead of residues shown in
brackets. (B) Minimal selenoprotein mRNA containing photoreactive groups: 4-thiouridine res-
idues (s4U) or aminoallyl-containing uridine residues bearing perfluorophenylazido group (N3R-
aaU, where R is perfluorophenyl residue). (C) Schematic description of the synthesis of N3R-
aaUTP used as a substrate to obtain N3R-aaU-containing SECIS.
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et al. 1996), was also constructed (Fig. 1A). The core repre-
sents the main binding site for SBP2, and mutations therein
lead to impairment of SBP2 binding in vitro and selenopro-
tein synthesis in vivo (Walczak et al. 1998; Copeland et al.
2000; Fletcher et al. 2001; Allmang et al. 2002; Cléry et al.
2007).
Ribosome binding activity
of the minimal mRNAs
in rabbit reticulocyte lysate
The functional activity of the minimal
mRNAs was assessed in micrococcal
nuclease-treated rabbit reticulocyte lysate
(RRL). RRL is amenable to studying sele-
noprotein synthesis because it contains
all the necessary components except
SBP2, which can be added as the recom-
binant protein (Copeland and Driscoll
2002). To freeze the ribosomes at various
steps of translation, we used the follow-
ing translation inhibitors: (1) the non-
hydrolyzable GTP analog, GMPPNP,
which inhibits translation at the stage
of 48S preinitiation complex formation
(Anthony and Merrick 1992); (2) aniso-
mycin, which blocks transpeptidation in
the 80S elongation complex (Anthony
and Merrick 1992); and (3) emetine,
which blocks translocation (Jimenez et
al. 1977). Complexes obtained with the
translational inhibitors were designated
as 48S, 80S-I, and 80S-II, respectively
(Fig. 2A). First, we examined whether
the minimal mRNAs can bind to ribo-
somes. To this end, RRL containing the
added SBP2 and 5 mM anisomycin was
incubated with the uniformly 32P-labeled
flSec and flPhe mRNAs. Subsequently,
the ribosomal 80S-I complex was isolated
by sucrose gradient centrifugation under
conditions of complex stability. Analysis
of the radioactivity in ribosome fractions
showed that the extent of mRNA binding
to the ribosomes was ∼0.35 mol mRNA
per mol of ribosomes for both types of
mRNAs (Fig. 2B).
Second, we asked whether the mini-
mal mRNAs were phased correctly on
the ribosome—in other words whether
the AUG codon was positioned in the
P site. Phasing was analyzed with the
primer extension inhibition method
(toe-printing). In this assay, a 32P-labeled
primer is annealed to the mRNA down-
stream from the assumed initiation site, and reverse tran-
scriptase is used to extend the radioactive primer up to the
mRNA position bound to the ribosome (Fig. 2C). In the
presence of GMPPNP, a toe-print was detected mostly at po-
sitions +16/+17 (Fig. 2C, lanes 1 and 5) with respect to the
first nucleotide of the triplet positioned in the P site (the
adenosine of AUG in this particular case), suggesting trans-
lation stopped at the stage of 48S preinitiation complex
FIGURE 2. Ribosome binding abilities of the minimal selenoprotein mRNA. (A) Schematic rep-
resentation of the complexes obtained from RRL with various translation inhibitors (concentra-
tion used is indicated). E, P, and A, tRNA binding sites. Initiation factors are displayed on the 48S
initiation complex. Charged tRNAs in 48S and 80S-I complexes as well as deacylated tRNA and
dipeptidyl tRNA in 80S-II complex are shown. (B) flSec mRNA (closed circles), flPhe mRNA
(closed squares), s4U-containing flSec mRNA (s4U-flSec mRNA, open circles), and s4U-contain-
ing flPhe mRNA (s4U-flPhe mRNA, open squares) binding to ribosomes in RRL. Note that the
concentration of the ribosomes in the RRL-based mixtures (50% of RRL v/v) was∼0.05 μM. The
data are the average of at least three independent experiments. The relative error was ∼10%. (C)
Toe-printing assay of 48S and 80S complexes formed in RRL with flPhe mRNA (lanes 1–4) and
flSec mRNA (lanes 5–8) in the presence of SBP2. Lanes 1 and 5: 48S complex; lanes 2 and 6: 80S-I
complex; lanes 3 and 7: 80S-II complex; translation inhibitors were omitted in lanes 4 and 8. (A,C,
G,T) Sequencing lanes, (ctrl) primer extension with no ddNTP added. Arrows indicate the bands
corresponding to toe-print signals. The two weak bands below the toe-prints in lanes 2 and 6 are
assigned to signals corresponding to the post-translocational complexes that could be formed in
insignificant amounts because of incomplete immobilization of ribosomes by anisomycin (by
analogy with Kozak [1998] where lower concentrations of anisomycin were used). The strong sig-
nal in the upper part of the gel in the flPhe RNA toe-printing lanes may reflect partial degradation
of the flPhe mRNA since it is present in all lanes with flPhe mRNA.
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formation (Dmitriev et al. 2003). The toe-print occurred
mostly at positions +17 and +18 in the case of emetine or ani-
somycin, respectively, with respect to the adenosine of the
AUG in the P site (Fig. 2C, lanes 2, 3, 6, 7), implying forma-
tion of the 80S initiation complex (Dmitriev et al. 2003). It is
unclear why the signal is stronger at +17 with emetine and at
+18 with anisomycin; possibly, the difference in the intensi-
ties of the 80S toe-print signals observed for the 80S-I and
80S-II complexes relate to different mechanisms of antibiotic
action. These results indicate that in RRL, the AUG start co-
don of the minimal flSec mRNA was correctly positioned in
the ribosomal P site, implying that the 3′ adjacent UGA Sec
codon was in the A site. To check whether the A and P sites
were indeed occupied by tRNAs, [5′-32P] pCp post-labeling
was carried out on the 3′ end of total RNA isolated from
48S, 80S-I, and 80S-II complexes assembled in RRL with
the flSec mRNA, in the presence of SBP2 (Fig. 3). The 80S-
I complex was also assembled on Mut1 mRNA (Fig. 1A) in
the presence of SBP2. Prior to labeling, total RNAwas treated
with Cu2+ to catalyze alkaline hydrolysis of the aminoacyl-
tRNA ester bond. This cation was shown to catalyze hydroly-
sis of the aminoacyl moiety in aminoacyl-tRNAs (Schofield
and Zamecnik 1968) but is unable to do so for the ester
bond between a dipeptide and a tRNA because of the large
distance between the free amino group and the ester bond
(see Lapidot and de Groot 1972 and references therein).
In control experiments, post-labeling was performed with
total RNA isolated from the endogenous complexes obtained
in micrococcal nuclease-treated RRL in the presence of
GMPPNP or antibiotic. Despite the high level of labeling of
the endogenous tRNAs isolated from control complexes
(Fig. 3, cf. lanes 1–3 and lanes 4–9), one can clearly distin-
guish the presence of a band migrating at the level of the
T7 tRNASec transcript, which shows up with the 80S-I com-
plex assembled on flSec mRNA in the presence of SBP2 only
(Fig. 3, cf. lane 5 with lane 10 and lane 5 with lanes 6 and 7).
Note that the appearance of this band is SBP2-dependent
since Mut1 mRNA, which contains substitutions in the
SECIS inhibiting SBP2 binding, obliterated it. Absence of
this band in lane 8 (80S-II complex) and its reappearance
in lane 9 (after alkaline hydrolysis of the ester bond in the
dipeptidyl-tRNA isolated from 80S-II complex) strongly
argues in favor of the A site occupation by a dipeptidyl-
tRNASec whose ester bond could not be hydrolyzed by the ac-
tion of Cu2+. It is worth mentioning here that the tRNASec
transcript migrated slightly slower than the endogenous
tRNASec because the transcript contains three additional Gs
at the very 5′ end in order to stimulate T7 transcription. All
this allowed us to conclude that the flSec mRNA was able
to form functional ribosomal complexes, where the P or P
and A sites were occupied by the cognate tRNAs.
Lastly, we verified whether the complexes formed in the
course of flSec mRNA translation contain SBP2. To this
end, we sought to detect the presence of SBP2 in the 48S,
80S-I, and 80S-II complexes described above. In control ex-
periments, we used ribosomes isolated from emetine- and
SBP2-containing RRL (with no minimal mRNA added)
and from a pretranslocation 80S-II complex formed with
the 5′ Phe mRNA, a construct containing the UUC codon in-
stead of UGA, and lacking the SECIS sequence (Fig. 4A).
mRNA•ribosome complexes were isolated from RRL by
sucrose gradient centrifugation, and the presence of SBP2
in ribosome fractions was verified by Western blotting.
Figure 4B (lanes 2–4 and 6) shows that SBP2 was present
only in the complexes formed in the presence of the flSec
mRNA but neither in the presence of the 5′ Phe mRNA
(Fig. 4B, lane 7) nor in the absence of mRNA (Fig. 4B, lane
8), indicating that insertion of SBP2 in the complex was
SECIS-mediated. It can be seen that the 48S, 80S-I, and
80S-II complexes (Fig. 4B, lanes 2–4) differed in the intensi-
ties of SBP2 signal, suggesting the different amounts of SBP2
in these complexes. To check whether emetine could block
the ribosomal binding site of SBP2 in control complexes,
FIGURE 3. A-site occupancy by the tRNASec. Analysis was carried out
on Cu2+-treated and 3′ end [32P]-labeled RNAs isolated from 48S and
80S complexes assembled in RRL on the endogenous (lanes 1–3) or
flSec mRNAs in the presence (lanes 4, 5, 8, 9) or absence (lane 6) of
SBP2, or from the 80S-I complex formed on the Mut1 mRNA (lane
7). Lanes 1 and 4: 48S complex; lanes 2, 5–7: 80S-I complex; lanes 3,
8, 9 (the sample was preliminarily treated at pH 9.0): 80S-II complex
(the weak bands observed in lane 9 but not in the other lanes could result
from slight RNA hydrolysis at pH 9.0); lane 10: T7 tRNASec transcript
(93 nt; it contains three additional Gs at the 5′ end compared to the au-
thentic tRNASec); lane 11: tRNAMet (76 nt); lane 12: total RNA isolated
from 60S subunits (5.8S rRNA, 160 nt; 5S rRNA, 120 nt). Arrows indi-
cate positions of the tRNAMet and tRNASec. The band just above the
tRNASec observed in lanes 2, 3 and 5–9 might correspond to partial hy-
drolysis of the 28S rRNA. The figure displays the autoradiogram corre-
sponding to the part of the gel where RNA fragments with a length lower
than 250 nt were resolved.
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we examined the binding of SBP2 with salt-washed ribo-
somes preincubated with emetine. It occurred that the pres-
ence of emetine did not change the ability of SBP2 to bind
the ribosome (Fig. 4B, lanes 10 and 11). Confirmation of
the SECIS-mediated SBP2 insertion in the ribosomal com-
plex was also obtained by using the Mut1 flSec mRNA mu-
tant (Fig. 1A). Figure 4C shows that, compared to the wild
type (WT), the mutation did not impede much the binding
of the mRNA to the ribosome in the presence of anisomycin
(binding extent of ∼30% for the WT and Mut1). SBP2 was
not detected in the ribosomal complex with Mut1 (Fig. 4C,
lower panel), a finding that was expected since the mutation
dramatically alters the SBP2 binding site (Allmang et al.
2002). Therefore, the flSec mRNA carrying the wild-type
GPx1 SECIS element supports formation of ribosomal com-
plexes in RRLwith SBP2 binding in a SECIS-dependentman-
ner. This mRNA can thus be used for investigating the SECIS
and SBP2 contacts in the course of translation.
SECIS-ribosome interactions during selenoprotein
mRNA translation
The 48S, 80S-I, and 80S-II complexes obtained with the
flSec and flPhe mRNAs are depicted in Figure 2A. For the in-
vestigations described in this paragraph, the flSec mRNA har-
bored a uniformly 32P-labeled SECIS element that contained
randomly inserted photoreactive s4U residues, enabling zero-
length cross-links upon UV irradiation (Fig. 1B). The control
flPhe mRNA was similarly prepared. The s4U-containing
mRNAs displayed the same ribosome binding efficiency as
the unmodified counterparts (Fig. 2B), meaning that intro-
duction of s4U did not interfere with the mRNA-ribosome
interaction. Both the flSec and flPhe mRNAs photoreactive
derivatives, as well as the same derivatives of the isolated
SECIS RNA, were able to cross-link to SBP2 in binary com-
plexes upon irradiation with mild UV light (data not shown).
To generate cross-links between the SECIS of the flSec
mRNA and the other components of the complexes men-
tioned above, the reaction mixtures were irradiated under
the same conditions.
After irradiation, complexes were separated from unbound
components, and the presence of SBP2 in the complexes was
confirmed by Western blotting (Fig. 5A). Proteins cross-
linked to the SECIS element were analyzed by SDS-PAGE af-
ter RNase A hydrolysis of the RNA segments unprotected by
the covalently linked proteins. With the 48S (Fig. 5B, lane 2)
and 80S-II (Fig. 5B, lane 6) complexes, the radioactive bands
migrated at the level of the SBP2 marker (Fig. 5B, lane 9). For
the 80S-I complex (Fig. 5B, lane 15), one can see two groups
of radioactive bands migrating at the level of ribosomal pro-
teins in the 10–20 kDa range (Fig. 5B, lanes 24, 25). The
bands, indeed, contained a protein moiety since proteinase
K treatment prior to SDS-PAGE loading led to their disap-
pearance (Fig. 5B, lanes 3, 4, 7, 8, 17, 18). Confirmation of
the identity of the bands displayed in lanes 2 and 6 (Fig.
5B) to SBP2 was brought by immunoprecipitation with
anti-SBP2 antibodies of the total proteins from the irradiated
48S and 80S-II complexes (Fig. 5C). The yield of SBP2 cross-
links with the SECIS in the 48S and 80S-II complexes was 2.3
± 0.3 times higher than the total yield of ribosomal protein
cross-links with the SECIS in 80S-I complex; this was evalu-
ated by densitometry of the gels shown in Figure 5B, taking
into account the longer exposure time to detect cross-links
with ribosomal proteins. Finally, the cross-links were specific
because the bands were lacking in control lanes with the 80S-I
complex formed with the s4U-containing flPhe mRNA
(when the A site was occupied by the Phe-tRNAPhe) in the ab-
sence (Fig. 5B, lanes 11–14) or presence (Fig. 5B, lanes 19–
22) of SBP2. In the latter case, a radioactive band migrating
at the level of SBP2 was observed (Fig. 5B, lane 19) as in
48S and 80S-II complexes with the flSec mRNA (Fig. 5B,
lanes 2 and 6); confirmation that it corresponded to the
cross-link of SBP2 with the s4U-containing SECIS element
of flPhe mRNA was obtained by immunoprecipitation, as
for complexes mentioned above (data not shown). This
band appeared because SBP2 bound to the SECIS of this
FIGURE 4. SBP2 content in ribosomal complexes formed in RRL. (A)
Minimal mRNAs used in the experiments. (B) The presence of SBP2
in complexes was shown by Western blotting with anti-SBP2 antibod-
ies. Lanes 2, 3, 4, and 6, complexes with flSec mRNA: lane 2, 48S pre-
initiation complex; lane 3, pretranspeptidation complex 80S-I; lanes 4
and 6, pretranslocation complex 80S-II; lane 7, 80S-II complex formed
with the 5′ Phe mRNA; lane 8, 80S ribosomes isolated from RRL in the
presence of emetine; lane 10, 80S•SBP2·complex formed in the pres-
ence of 1 mM emetine; lane 11, 80S•SBP2·complex formed without
emetine; lanes 1, 5, and 9, controls containing purified recombinant
SBP2. The amount of SBP2 detected in the complexes is indicated be-
low the panel; the amount of SBP2 detected in the 80S-I complex was
taken as 100%. (C) flSec mRNA WT and Mut1 mRNA binding to ri-
bosomes in the presence of 5 mM anisomycin (80S-I complex). The
relative error in determining the binding extent of these mRNAs
with ribosomes was ∼10%. The data are the average of at least three
independent experiments. The presence of SBP2 in 80S-I complexes
was assayed by Western blotting with anti-SBP2 antibodies (shown
in the lower panel).
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mRNA was not involved in aminoacyl-tRNA binding to the
ribosomal A-site, whereas this was the case in the complex
with the flSec mRNA (Fig. 5B, lane 15). The lack of the
SECIS-ribosome cross-link, when the 80S-I complex was
formed with s4U-containing flPhe mRNA in the presence
of SBP2, argues in favor of the A site-bound-Sec-tRNASec-de-
pendent nature of the cross-link between the s4U-containing
flSec mRNA and ribosomes in the 80S-I complex. This cross-
link could be considered as SBP2-dependent since binding of
the Sec-tRNASec at the ribosomal A site was mediated by the
SECIS-bound SBP2. Based on the cross-linking data, we con-
clude that the SECIS element of the flSec mRNA contacts the
ribosome only in the 80S-I complex, whereas it establishes
contacts with SBP2 in the 48S preinitiation and 80S-II pre-
translocation complexes.
Similar experiments were performed to check whether the
SECIS element of the flSec mRNA could cross-link to ribo-
somal RNAs. After cross-linking, RRL was treated with pro-
teinase K to hydrolyze proteins, and total RNA was resolved
on denaturing 5% PAGE. No SECIS-
rRNA cross-link could be observed un-
der such conditions (data not shown).
To determine which ribosomal sub-
unit contacts the SECIS element, the
80S-I complex was formed using the
flSec mRNA harboring a uniformly 32P-
labeled SECIS element with randomly in-
serted s4Us. After UV irradiation, the
complex was isolated by sucrose gradient
centrifugation and further run on a sec-
ond sucrose gradient under conditions
allowing ribosome subunit dissociation.
Analysis of the gradient fractions revealed
the presence of radioactivity only in the
60S subunit fraction upon UV irradiation
but not with untreated samples (Fig. 6A).
Therefore, incorporation of radioactivity
into the 60S subunit was caused by cross-
linking of the flSec mRNA SECIS ele-
ment to the 60S subunit in the 80S-I
complex. The cross-linking yield was
<1% of the flSec mRNA bound to ribo-
somes. Thus, it is likely that the proteins
observed in Figure 5B, lane 15 were 60S
subunit proteins cross-linked to the
SECIS element of the flSec mRNA. No
notable increase in the cross-linking yield
was detected when the SECIS RNA
was derivatized with randomly inserted
aminoallyl-containing uridine residues
bearing perfluorophenylazido groups
(see Fig. 1B and C; cross-linking radius
∼17Å) instead of s4U (Fig. 6B). The low
cross-linking yield and its scattering
among several ribosomal proteins (Fig.
5, lane 15) made us unable to identify the cross-linked pro-
teins, but on the other hand, it definitely indicated the ab-
sence of rigid contact of the SECIS with the ribosome.
DISCUSSION
Deciphering the mechanism of selenocysteine incorporation
during selenoprotein synthesis remains a challenging task.
While most, if not all, of the numerous molecular actors in-
volved have been identified (Allmang et al. 2009), the mech-
anistic issues are still shrouded in mystery. The question is
even more acute when considering the case of the selenopro-
tein P mRNA, which contains 10–17 UGA Sec codons and
two SECIS elements (Stoytcheva et al. 2006). In an attempt
to increase our knowledge, in the work described here, we de-
signed for the first time a minimal capped selenoprotein
mRNA bearing photoreactive groups in the SECIS element.
Its use enabled us to localize SBP2 at different translation
steps and to obtain a novel insight into selenoprotein
FIGURE 5. Cross-linking of minimal s4U-containing mRNAs in RRL. (A) The presence of SBP2
in complexes formed with the flSec mRNA shown by Western blotting. Lane 1: purified recom-
binant SBP2 as the control; lane 2: 48S complex; lane 3: 80S-I complex; lane 4: 80S-II complex. (B)
Autoradiograms of the SDS-PAGE of the proteins cross-linked with the uniformly 32P-labeled
s4U-containing SECIS of flSec mRNA (lanes 1–8 and 15–18) or flPhe mRNA (lanes 11–14 and
19–22), in the presence (+) or absence (−) of SBP2 and UV light. Exposure time: 12 h for the
48S and 80S-II complexes, 48 h for the 80S-I complex. (+ RNase A or + Prot K) Complexes treat-
ed with RNase A or proteinase K, respectively. Lanes SBP2, L30 (ribosomal protein L30), TP80,
TP60, and TP40 (total proteins from 80S ribosomes, 60S, and 40S subunits, respectively) were
Coomassie-stained. (C) Validation of SBP2 cross-links obtained in 48S and 80S-II complexes
by immunoprecipitation using anti-SBP2 antibodies. Bars 1: immunoprecipitation of the total
proteins from the irradiated ribosomal complexes separated from unbound components; bars
2: same as in bars 1 but with beads lacking antibodies; bars 3: immunoprecipitation of the total
proteins from the irradiated ribosome complexes obtained with flPhe mRNA but without SBP2.
The data represent the mean and standard deviation of three independent experiments.
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synthesis. It should be noted that, in our minimal mRNAs,
the UGA Sec codon was separated from the stop codon by
two triplets, a distance similar (1–3 triplets) in at least six hu-
man selenoprotein mRNAs (SelK, SelO, SelP, SelS, TRI,
TRII) (Castellano et al. 2008). It is unlikely at this stage of
our knowledge that the distance between the UGA Sec and
the stop codon could influence the mechanism of selenocys-
teine incorporation into the growing polypeptide chain.
Study of selenocysteine incorporation with engineered
minimal selenoprotein mRNA
Isolated SECIS RNAs were previously used by other investi-
gators as cross-linking probes to fish out possible molecular
partners. SECIS-binding proteins such as SBP2, ribosomal
protein L30, the exon-junction complex protein eIF4a3, and
nucleolin were thus identified (Copeland and Driscoll 1999;
Chavatte et al. 2005; Budiman et al. 2009; Miniard et al.
2010). The isolated SECIS RNA was also the mainstay to get
insight into the mechanism of selenoprotein synthesis. In
this respect, twomodels for selenocysteine insertionwere pro-
posed. In the first one, SBP2 is permanently associated with
a subset of ribosomes and binds the SECIS element after the
ribosome reaches a UGA Sec codon (Donovan et al. 2008).
The second model marks a notable difference. SBP2 is asso-
ciated with the SECIS element and, after positioning of the
UGA Sec codon into the ribosomal A site, ribosomal protein
L30 displaces SBP2 from the SECIS, causing conformational
rearrangements in the SECIS and thus induces release of the
eEFSec•Sec-tRNASec•GTP complex (Chavatte et al. 2005).
However, mechanistic issues are still bitterly missing to
validate one model or the other. To obtain a more detailed
insight into the selenocysteine insertion mechanism, we
have chosen in this study an approach using minimal seleno-
protein mRNAs instead of the isolated SECIS RNA (Chavatte
et al. 2005; Donovan et al. 2008). The minimal selenoprotein
mRNAwas engineered from two RNA pieces that were sealed
by splint-aided T4 DNA ligation. The mRNAwas designed so
as to contain all the indispensable func-
tional parts, including the SECIS element
in the 3′ UTR. In preliminary experi-
ments, we showed that, in rabbit retic-
ulocyte lysate, such synthetic mRNAs
enabled formation of active SBP2-con-
taining selenoprotein mRNA•ribosome
complexes mimicking various ribosomal
states occurring in the course of transla-
tion. The great advantage of using such
mRNAs ligated from separate RNA
pieces resides in the possibility of insert-
ing cross-linking reagents only into the
SECIS element. As a matter of fact,
cross-linking approaches with the use of
short mRNA molecules (6–350 nt) bear-
ing photoreactive groups have been suc-
cessfully used to study mRNA-ribosome interactions in
various translation complexes (Graifer et al. 2004; Laletina
et al. 2006; Pisarev et al. 2008; Graifer and Karpova 2012).
In the present study, a minimal selenoprotein mRNA was
constructed that harbored different photoreactive groups in
the SECIS element: either randomly distributed 4-thiouri-
dines or randomly inserted aminoallyl-containing uridine
residues bearing perfluorophenylazido groups.
SBP2 is bound to the SECIS element of selenoprotein
mRNAs in translation-competent complexes
We showed by cross-linking that SBP2 is already bound to
the SECIS element of selenoprotein mRNA in the 48S initia-
tion complex. Nevertheless, it is still unclear whether SBP2
remains free in solution and binds the SECIS element only
once the selenoprotein mRNA is recruited to the 40S subunit
or is permanently complexed with the selenoprotein mRNA
before contacting the ribosome. The latter possibility seems
more likely since SBP2 was found associated with selenopro-
teinmRNAs in vivo by immunoprecipitation (Copeland et al.
2000). The identification of nuclear export and localization
signals in SBP2 (Papp et al. 2006) and of additional nuclear
proteins participating in SECIS-SBP2 complex formation
(Boulon et al. 2008) strongly suggests that SBP2 is bound
to the SECIS of selenoprotein mRNA in the nucleus. Taking
all this into account, plus the cross-links of SBP2 with the
SECIS elements of the flSec mRNA in the 80S-II pretranslo-
cation complex and of the flPhe mRNA in the 80S-I complex
(where UUC in the A site was occupied by the cognate
tRNA), one can conclude that SBP2 travels associated with
the SECIS element of selenoprotein mRNA before contacting
the ribosome.
Nature of the SECIS-ribosome and SBP2-ribosome
interactions
According to our data, the SECIS element contacts the ribo-
some in the 80S-I complex where transpeptidation is blocked
FIGURE 6. Sucrose gradient sedimentation profile of the 60S and 40S ribosomal subunits isolat-
ed from the irradiated 80S complex formed in RRL in the presence of 5mM anisomycin with flSec
mRNA bearing SECIS derivatized with either (A) statistically distributed s4Us or (B) randomly
inserted N3R-aaUs. Solid line, A260; dashed line, radioactivity corresponding to irradiated
(open circles) and nonirradiated (closed circles) complexes. The relative error in determining
the amount of radioactivity in the fractions was ∼10%; the data are the average of the three in-
dependent experiments.
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(shown by cross-linking), but these contacts are flexible, as
inferred from the distribution of cross-linked SECIS over sev-
eral ribosomal proteins. SBP2 is present in the 80S-I complex
(shown by Western blotting), but it remains unclear whether
it contacts the SECIS in this complex, because the lack of
cross-link between SBP2 and the SECIS does not necessarily
mean absence of SBP2-SECIS contacts. Therefore, two possi-
bilities of SBP2 interaction in the 80S-I complex should be
considered. In the first one, SBP2 in this complex could
not interact with the SECIS element at all and contacted
only the ribosome. It is likely that SBP2 binding to the ribo-
some is accompanied by conformational rearrangements in
the SECIS element, leading to a decrease of SBP2 affinity to
the SECIS, thus promoting SBP2 association with the 60S
subunit. The second possibility suggests that SBP2 was bound
both to the ribosome and the SECIS; this suggestion is sup-
ported by the larger amount of SBP2 in the 80S-I complex
as compared with those in 48S and 80S-II complexes, indicat-
ing stabilization of the 80S-I complex by SBP2 contacts with
both the SECIS element of the mRNA and the ribosome.
However, cross-linking between SBP2 and the s4U moieties
in the SECIS of the flSec mRNA did not occur for some rea-
son. The lack of cross-link could be caused either by inappro-
priate orientation of the SECIS s4U moieties with respect to
SBP2 in this complex (for example, SBP2 could interact with
the SECIS element via the sugar-phosphate backbone) or by
poor reactivity of an SBP2 amino acid residue(s) contacting a
photoactivated s4U. All this could happen because of either
(1) conformational rearrangements in the SBP2 binding
site on the SECIS (allowing SBP2 to bind both with the ribo-
some and the SECIS), or (2) structural changes in the SBP2
region interacting with the SECIS. Indeed, it is difficult to
imagine simultaneous binding of SBP2 with the ribosome
and the SECIS without such rearrangements since the SBP2
sites for SECIS and ribosome binding overlap significantly
(Copeland et al. 2001; Takeuchi et al. 2009). Thus, whatever
the interactions of SBP2 in the 80S-I complex, they should in-
volve conformational changes in the SECIS element and, pos-
sibly, in SBP2. The cross-linking of SBP2 to the SECIS
element of the flSec mRNA in the pretranslocation 80S-II
complex indicates that, at least after transpeptidation, the
SECIS element and SBP2 adopt the initial conformations fa-
vorable for cross-linking.
Thus, SBP2 could bind the ribosome either during
eEFSec•Sec-tRNASec•GTP complex delivery to the ribosomal
A site or during Sec-tRNASec accommodation to this site.
SBP2 could also be bound to the SECIS element at these
steps. Worthy of note, recent data reported a higher accessi-
bility of helix H89 of the 28S rRNA due to conformational
changes induced by SBP2 binding to the 80S ribosome
(Caban and Copeland 2012), and that Domain IV of elon-
gation factor eEFSec is involved in Sec-tRNASec binding,
interactions with SBP2, and regulating GTPase activity
(Gonzalez-Flores et al. 2012). Based on these findings, the
authors proposed that, when the eEFSec•Sec-tRNASec•GTP
ternary complex appears near the ribosomal A site, the
SECIS-bound SBP2 and helix H89 of the 28S rRNA interact
with Domain IV of eEFSec to dissociate the ternary complex
and to deliver the Sec-tRNASec to the A site (Gonzalez-Flores
et al. 2012). This implies that SBP2 binds both to the SECIS
and the 60S ribosomal subunit before accommodation of the
Sec-tRNASec to the A site. Our data show that SBP2 stays
bound to the ribosome and, possibly, to the SECIS after ac-
commodation of Sec-tRNASec to the A site; SBP2 dissociates
from the ribosome during or after peptide bond formation,
manifesting again its high affinity for the SECIS element
(as shown by cross-linking of SBP2 with the SECIS in the
80S-II complex). What does make SBP2 dissociation possi-
ble? We propose that conformational changes in the 28S
rRNA near the peptidyl-transferase center accompanying
transpeptidation propagate to the SBP2 binding site on the
60S subunit, resulting in significant lowering of SBP2 affinity
for the ribosome. To decipher this more deeply and to clarify
all the questions that arose, additional investigations are re-
quired that are outside the scope of this work.
The findings presented herein provide new information
concerning the molecular mechanism of selenocysteine in-
sertion into selenoproteins with regard to SBP2-SECIS,
SBP2-ribosome, and SECIS-ribosome interactions. The use
of minimal selenoprotein mRNA containing all the known
functional parts found in natural selenoprotein mRNAs
made it possible to arrive at a new point of view, stating
that the SECIS of mRNA is associated with SBP2 already at
the step of 48S initiation complex formation. The second
novelty is that SBP2 stays bound to the ribosome after Sec-
tRNASec accommodation to the A site and dissociates during
transpeptidation. The third novelty is that the SECIS element
in the selenoprotein mRNA contacts the 60S ribosomal sub-
unit after Sec-tRNASec accommodation. Lastly, our findings
led us to propose that incorporation of the Sec residue into
the polypeptide chain is governed by conformational rear-
rangements in both the SECIS and 28S rRNA. Future struc-
tural and biochemical experiments will be required to
provide a more complete mechanistic picture.
MATERIALS AND METHODS
Synthesis of the minimal selenoprotein mRNAs
Minimal selenoprotein mRNAs were obtained by splint-aided liga-
tion with T4 DNA ligase of a 5′ RNA segment containing the 5′
UTR, a short coding region, and part of the 3′ UTR, and a 3′
RNA consisting of the remainder of the 3′ UTR with the SECIS el-
ement. The 5′ RNA contained either the UGA Sec or a UUC Phe co-
don as the control. The whole procedure is described below.
Synthesis of the 5′ RNAs
The DNA template for 5′ RNA synthesis was obtained by PCR. A
typical reaction contained 1 μM 5′-UTR and 3′-UTR primers, and
Kossinova et al.
8 RNA, Vol. 19, No. 8
 Cold Spring Harbor Laboratory Press on June 12, 2017 - Published by rnajournal.cshlp.orgDownloaded from 
0.05 μM Sec or Phe primers in 50 μL of DyNAzyme buffer
(Finnzymes) containing 0.2 mM dNTPs and 1 unit of DNA poly-
merase DyNAzyme EXT (Finnzymes). Amplification was carried
out in Progene amplificator (Techne), using the following program:
94°C for 30 sec, 55°C for 30 sec, and 68°C for 30 sec (30 cycles).
Primer sequences (5′ to 3′) are as follows: 5′-UTR–AAATTAAT
ACGACTCACTATAGGGAGAAAAAAGAAAGAAATG, 3′-UTR
(2′OMe-G)(2′OMe-C)–TTCCTTCGTGTCTTTGTCTTTTTTC
TTTTTCTTTTCTTTCTTCT, Sec–TTCTTTTCTTTCTTCTTAG
AAGAATCACATTTCTTTCTTTTTTC, Phe–TTCTTTTCTTTCTT
CTTAGAAGAAGAACATTTCTTTCTTTTTTC. The resulting DNA
templates were used to synthesize the RNA transcripts by T7 tran-
scription in vitro. The resulting RNAs were purified on sephadex
G15 mini-spin columns (Thermo Scientific). The RNAs were desig-
nated as 5′ Sec RNA and 5′ Phe RNA.
Sequences of the RNAs were 5′-gggagaaaaaagaaagaaauguga
uucuucuaagaagaaagaaaagaaaaagaaaaaagacaaagacacgaaggaaga-3′ and
5′-ggagaaaaaagaaagaaauguucuucuucuaagaagaaagaaaagaaaaagaaaaaag
acaaagacacgaaggaaga-3′ for the 5′ Sec RNA and 5′ Phe RNA, respec-
tively (coding region and stop codon are shown in bold).
Synthesis of the 3′ RNA
The wild type and the mutant of the glutathione peroxidase 1
(GPx1) SECIS RNA were used as 3′ RNA (Fig. 1A). Mutant Mut1
converted the non-Watson-Crick base pair quartet to four
Watson-Crick base pairs. Plasmids pT7Bck-GPx and pT7Bck-
G24, encoding the WT and the Mut1 SECIS, respectively (Walczak
et al. 1998), were linearized with EcoRI and used as DNA templates
for the T7 transcription reaction carried out as described (Fagegalt-
ier et al. 2000b). To obtain uniformly 32P-labeled RNA, 100 μCi of
[α-32P] ATP (3000 Ci/mmol) were added. To synthesize RNA with
randomly distributed 4-thiouridines (s4U), the UTP concentration
was reduced to 2mM, and s4UTPwas added to 0.5 mM. Taking into
account that the s4U insertion efficiency is ∼4.5 times less than that
of U (Dubreuil et al. 1991), and the concentration of s4UTP was
four times lower than that of UTP, one can assume that no more
than two out of the 32 uridine residues in the GPx1 SECIS (and
flanking sequences) were substituted by s4U residues. The same pro-
cedure was applied to synthesize uniformly 32P-labeled RNA with
randomly distributed aminoallyl-containing-uridine residues bear-
ing perfluorophenylazido groups (N3R-aaU). Prior to synthesis,
N3R-aaUTP was synthesized by benzoylation of the aliphatic amino
group of aaUTP with the N-oxysuccinimide ester of 4-azidotetra-
fluorobenzoic acid, as described (Fig. 1C; Graifer and Karpova
2012). RNA purification was carried out as above.
Preparation of full-length minimal mRNAs
and their photoreactive derivatives by splint-aided
T4 DNA ligation
flSec and flPhe mRNAs (Fig. 1A) were obtained by splint-aided liga-
tion of the 5′ and 3′ RNAs with T4 DNA ligase. A typical reaction
mixture contained 150 pmol of 5′ RNA, 150 pmol of the splint oli-
gonucleotide 5′-GTGATCACCAAGCCCGCTTCCTTCGTGTCT-
3′ and 120 pmol of 3′ RNA (SECIS GPx1, WT or mutant), 20 units
of RNasin, and 100 units of T4 DNA ligase (Epicentre) in 100 μL of
T4 DNA ligase buffer (Epicentre). After gel purification and elution,
the yield of the ligated product was 10%–12%. Capping of mRNA
was carried out using the ScripCap m7G Capping System (Epi-
centre). To obtain the mRNAs in large quantities, the products of
the 5′ RNA and 3′ RNA T4 DNA ligation were reverse-transcribed.
The resulting cDNAswere PCR-amplified and used for T7 transcrip-
tion. The mRNA was 32P-labeled and purified as described above.
The sequences of the resulting minimal RNAs were 5′-ggga
gaaaaaagaaagaaaugugauucuucuaagaagaaagaaaagaaaaagaaaaaagac
aaagacacgaaggaagagggcuuggugaucacuggcugcccuccgggggggagguuuuucca
ugacguguuuccucuaaauuuacauggagaaacaccugauuuccagaaaaauccccucag
augggcgcugguaccgagcucg-3′ for the flSec mRNA and 5′-gggagaaaaaag
aaagaaauguucuucuucuaagaagaaagaaaagaaaaagaaaaaagacaaagacacg
aaggaagagggcuuggugaucacuggcugcccuccgggggggagguuuuuccaugacgug
uuuccucuaaauuuacauggagaaacaccugauuuccagaaaaauccccucagauggg
cgcugguaccgagcuc-3′ for the flPhemRNA (coding region and stop co-
don are shown in bold; a part of GPx1 3′ UTR containing SECIS is
shown in italics).
Photoreactive derivatives of flSec and flPhe mRNAs were ob-
tained using the same procedure; uniformly 32P-labeled 3′ RNA
(SECIS GPx1; 25,000 cpm/pmol) bearing statistically introduced
photoreactive groups was used as 3′ RNA. Purification and capping
of the mRNA derivatives were carried out as described above. The
yield of the photoreactive derivatives was 10%–12%.
Preparation of recombinant proteins
The C-terminal part of human SBP2 (aa 343–854) fused to an
N-terminal 6×His tag was expressed in Escherichia coli BL21(DE3)
RIL strand (Novagene) as described (Takeuchi et al. 2009). Recom-
binant ribosomal protein L30 was kindly provided by A. Shmakova
(Institute of Chemical Biology and Fundamental Medicine, Siberian
Branch of the Russian Academy of Sciences).
Toe-printing assay
The mixture containing 50% (v/v) of micrococcal nuclease-treated
rabbit reticulocyte lysate (Promega), 10 units of RNasin, 0.25 mM
amino acid mixture in 10 μL of buffer A (20 mM HEPES-KOH
pH 7.8, 100 mM KOAc, 2 mM Mg[OAc]2, 0.25 mM spermidine,
and 10mM sodium creatine phosphate), 1mMATP, 0.1 μMrecom-
binant C-terminal SBP2, and 2 mM GMPPNP or 0.5 mM GTP, to-
gether with antibiotic (either 2 mM emetine or 5 mM anisomycin)
was preincubated for 5 min at 30°C. Then, capped mRNA (0.3
pmol) was added, and the mixture was incubated for an addition-
al 5 min at 30°C. The reverse transcription and the resulting
cDNA products analysis were carried out as described (Dmitriev
et al. 2003). After electrophoresis, the gel was dried, exposed to a
BioRad Phosphorimager plate, and analyzed using the QuantityOne
program (BioRad).
mRNA-ribosome binding in rabbit reticulocyte lysate
The mixture contained 100 μL micrococcal nuclease-treated RRL,
10 units of RNasin, and 0.25 mM amino acid mixture in 200 μL
of buffer A. Prior to adding the mRNA, the mixture was supple-
mented with recombinant SBP2 (0.25 μM) and 5 mM anisomycin,
and incubated at 30°C for 5 min. After mRNA addition (concentra-
tion of the mRNA was 0.05, 0.1, 0.15, 0.25, or 0.35 μM; specific ra-
dioactivity was ∼10,000 cpm/pmol), the mixture was incubated at
30°C for 15 min, then layered onto a 5%–40% sucrose gradient in
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buffer B (20 mM HEPES-KOH pH 7.8, 100 mM KOAc, and 2 mM
Mg[OAc]2) and centrifuged at 52,000 rpm for 2.5 h at 4°C in an
SW60 rotor. After centrifugation, gradient fractions were collected.
To analyze the binding of mRNA with the ribosome, the radioactiv-
ity of each gradient fraction was measured, and the binding efficien-
cy was calculated (mol of mRNA/mol of ribosomes).
SBP2 content in ribosomal complexes
80S or 48S complexes were assembled in 200 μL of buffer A (50% v/v
of RRL) as described in the previous section, except that themixtures
were supplementedwith 50 pmol of SBP2 and 50pmol of 32P-labeled
mRNA (flSec mRNA, Mut1 mRNA, or 5′ Phe mRNA; 10,000 cpm/
pmol). Ribosomal complexes were isolated by centrifugation in the
sucrose density gradient as described above. After centrifugation
and fractionation, fractions corresponding to ribosomal complexes
were TCA-precipitated. The resuspended pellet was loaded onto
10% SDS-PAGE, which was blotted onto Immobilon membranes
(Millipore). The SBP2 signal was detected with rabbit polyclonal
anti-SBP2 antibodies, which were shown beforehand not to cross-
react with ribosomal proteins (1/2500 dilution). Membranes were
treated with anti-rabbit HRP-conjugated secondary antibody (1/
10,000 dilution), revealed with the ECL-plus kit (GE Healthcare),
and exposed to either X-ray film or ChemiDoc XRS (BioRad).
tRNA 3′ end post-labeling
Ribosomal complexes 48S, 80S-I, and 80S-II with flSec mRNA and
respective control complexes without mRNA added were assem-
bled, isolated, and ethanol-precipitated as described above. Control
80S-I complexes were also assembled on Mut1 mRNA in the pres-
ence of SBP2 and on flSec mRNA in the absence of SBP2. The pellet
was dissolved in 100 μL of 0.1% SDS containing 1 mM EDTA and
incubated at 37°C for 10 min. After phenol-chloroform extraction
and ethanol precipitation, the resulting total RNA was dissolved in
40 μL of H2O. One quarter of the extracted RNA was incubated in
50 μL of 150 mM NaOAc pH 5.5 containing 10 mM CuSO4 as de-
scribed (Roessler et al. 1989), ethanol-precipitated, dissolved in
20 μL of H2O and 3′ end-labeled with 20 μCi of [5′-
32P] pCp using
T4 RNA ligase. The rest of the total RNA obtained from the 80S-II
complex was incubated in 50 mM Tris-HCl pH 9.0 for 1 h at 25°C,
precipitated, and subjected to 3′ end labeling, too. The bovine
tRNASec marker was obtained by T7 transcription after Bst2U I
(SibEnzyme) plasmid linearization (Sturchler et al. 1995). Marker
RNAs (tRNASec, tRNAMet, flSec RNA, 5S rRNA, and 5.8S rRNA)
were 3′ labeled with [5′-32P] pCp. The resulting labeled RNAs
were analyzed by 10% denaturing PAGE; the gel was treated and an-
alyzed as described above.
mRNA–ribosomes cross-linking in RRL
The mRNA•ribosome complexes were assembled in 120 μL RRL as
described in the previous section, except that the minimal mRNA
harbored an s4U-containing uniformly 32P-labeled SECIS. To gen-
erate cross-links, reaction mixtures were placed on ice in 96-well
plates containing 25-μL aliquots and irradiated for 2 min with a
SpotCure UV lamp (λ > 290 nm), shorter wavelengths being cut
off using a thin glass filter (in order to avoid direct UV-induced
cross-linking). 2-mercaptoethanol was added to the irradiated com-
plexes to 0.17% final concentration. Control reactions were not ir-
radiated and kept on ice. Prior to complex formation, the activity
of the photoreactive groups introduced into the SECIS of flSec
and flPhe mRNAs was examined by cross-linking the mRNA deriv-
atives (0.05 μM) to SBP2 (0.15 μM) under conditions described
above. The cross-linked products were analyzed by 14% SDS-
PAGE after preliminary RNase A hydrolysis of the RNAmoieties at-
tached to proteins. To reveal the cross-links, gels were fixed in eth-
anol/AcOH, dried, and exposed to a PhosphorImager plate and
analyzed using the QuantityOne program (BioRad). The same pro-
cedure was carried out to control the activity of the photoreactive
groups introduced into the SECIS RNA before using the SECIS
RNA derivatives for ligation with the 5′ RNA moiety to obtain the
full-length minimal mRNA.
Analysis of cross-linked proteins and rRNA
To analyze protein cross-links, mixtures were layered after irradia-
tion onto 10%–30% sucrose gradients in buffer B and centrifuged
at 22,000 rpm at 4°C for 17 h in an SW40 rotor. After centrifugation,
fractions corresponding to 80S or 48S complexes were TCA-precip-
itated. The pellets were dissolved in 50 μL of water, 10 μL were taken
for Western blot analysis, and the remainder was treated with 0.1%
SDS containing 0.5 mM EDTA and incubated at 37°C for 10 min to
dissociate ribosomal particles into proteins and rRNAs. Then, 10 μg
of RNase A (Sigma) were added to hydrolyze the RNA. After incu-
bation (1 h, 37°C), mixtures were divided into two parts. The pro-
teins from one half were precipitated with six volumes of acetone,
while the other half was treated with 10 μg of proteinase K, incubat-
ed for an additional 30 min at 37°C, and precipitated with acetone.
Samples were analyzed as described above. After electrophoresis,
gels were handled as described above. SBP2-flSec mRNA cross-links
were assessed by immunoprecipitation as in Babaylova et al. (2009).
To identify cross-links with rRNA, 30 μL of each mixture were di-
luted after irradiation with two volumes of 0.3M NaOAc pH 5.5
containing 1% SDS and 0.5 mM EDTA, and incubated for 15 min
at 37°C; 30 μg of proteinase K were then added, and reactions
were incubated for 30 min at 37°C. After phenol-chloroform extrac-
tion, the rRNA was ethanol-precipitated and loaded onto 5% de-
naturating PAGE. Gels were stained with ethidium bromide and
visualized by ChemiDoc. The gel was then dried, exposed to Phos-
phorImager plate, and analyzed by densitometry using the
QuantityOne software (BioRad). The SBP2 content in each complex
was analyzed by Western blotting as described above.
Analysis of cross-link distribution between
ribosomal subunits
To determine which ribosomal particle contacts the SECIS element,
ribosome•flSec mRNA complexes were formed in RRL in the pres-
ence of anisomycin and irradiated as described above. Control reac-
tions were not irradiated and were kept on ice. 80S ribosomal
complexes were isolated by 10%–30% sucrose gradient centrifuga-
tion as described above. Fractions corresponding to 80S complexes
were ethanol-precipitated. The pellets were dissolved in 100 μL of
buffer C (20 mM Tris-HCl pH 7.5, 3 mM MgCl2, 100 mM KCl,
and 0.15 mM EDTA) and 30 pmol of 40S and 40 pmol of 60S car-
rier subunits were added together with puromycin (0.5 mM final
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concentration), and the mixture was kept on ice for 10 min. Ribo-
somal subunits were dissociated by increasing the KCl concentra-
tion to 450 mM, with subsequent incubation for 30 min at 37°C
and then centrifuged on 10%–30% sucrose gradient for 17 h at
25,000 rpm in buffer C containing 450 mM KCl. Radioactivity in
each gradient fraction was measured, and the extent of the sub-
unit(s) modification was calculated.
ACKNOWLEDGMENTS
We thank C. Allmang (IBMC, Strasbourg) for helpful discussion,
advice, and a gift of materials. We thank A. Schweigert and S. Bau-
drey for technical assistance. O.K. was a cosupervised Ph.D. student
with the Institute of Chemical Biology and Fundamental Medicine
and the Université de Strasbourg, partly supported by the French
government. This work was supported in part by the ARCUS and
Supramolecular Chemistry programs (to G.K. and A.K.). It was car-
ried out under the auspices of the Laboratoire International Associé
LIA NUCPROT and supported by the Russian Foundation for Basic
Research (grant 12-04-93111-CNRSL_a to G.K.).
Received October 12, 2012; accepted May 15, 2013.
REFERENCES
Allmang C, Carbon P, Krol A. 2002. The SBP2 and 15.5 kD/Snu13p
proteins share the same RNA binding domain: Identification
of SBP2 amino acids important to SECIS RNA binding. RNA 8:
1308–1318.
Allmang C, Wurth L, Krol A. 2009. The selenium to selenoproteins
pathway in eukaryotes: More molecular pathways than anticipated.
Biochim Biophys Acta 1790: 1415–1423.
Anthony DD, Merrick WC. 1992. Analysis of 40S and 80S complexes
withmRNA asmeasured by sucrose density gradients and primer ex-
tension inhibition. J Biol Chem 267: 1554–1562.
Babaylova E, Graifer D, Malygin A, Stahl J, Shatsky I, Karpova G. 2009.
Positioning of subdomain IIId and apical loop of domain II of the
hepatitis C IRES on the human 40S ribosome. Nucleic Acids Res
37: 2126–2141.
Böck A, Rother M, Leibundgut M, Ban N. 2006. Selenium metabolism
in prokaryotes. In Selenium: Its molecular biology and role in human
health, 2nd ed. (ed. DL Hatfield, et al.), pp. 9–28. Springer Verlag,
New York.
Boulon S, Marmier-Gourrier N, Pradet-Balade B, Wurth L,
Verheggen C, Jady BE, Rothe B, Pescia C, Robert MC, Kiss T,
et al. 2008. The Hsp90 chaperone controls the biogenesis of L7Ae
RNPs through conserved machinery. J Cell Biol 180: 579–595.
Bubenik JL, Driscoll DM. 2007. Altered RNA binding activity underlies
abnormal thyroid hormonemetabolism linked to amutation in sele-
nocysteine insertion sequence-binding protein 2. J Biol Chem 282:
34653–34662.
Budiman ME, Bubenik JL, Miniard AC, Middleton LM, Gerber CA,
Cash A, Driscoll DM. 2009. Eukaryotic initiation factor 4a3 is a sele-
nium-regulated RNA-binding protein that selectively inhibits sele-
nocysteine incorporation. Mol Cell 35: 479–489.
Bulygin K, Chavatte L, Frolova L, Favre A, Karpova G. 2005. The first
position of a codon placed in the A site of the human ribosome con-
tacts nucleotide C1696 of the 18S rRNA as well as proteins S2, S3,
S3a, S30 and S15. Biochemistry 44: 2153–2162.
Caban K, Copeland PR. 2012. SECIS binding protein 2 alters the confor-
mational dynamics of residues involved in tRNA accommodation in
80S ribosomes. J Biol Chem 287: 10664–10673.
Caban K, Kinzy SA, Copeland PR. 2007. The L7Ae RNA binding motif is
a multifunctional domain required for the ribosome-dependent sec
incorporation activity of Sec insertion sequence binding protein 2.
Mol Cell Biol 27: 6350–6360.
Castellano S, Gladyshev VN, Guigo R, Berry MJ. 2008. SelenoDB 1.0: A
database of selenoprotein genes, proteins and SECIS elements.
Nucleic Acids Res 36: D332–D338.
Chambers I, Frampton J, Goldfarb P, Affara N,McBainW,Harrison PR.
1986. The structure of the mouse glutathione peroxidase gene: The
selenocysteine in the active site is encoded by the ‘termination’ co-
don, TGA. EMBO J 5: 1221–1227.
Chavatte L, Brown BA, Driscoll DM. 2005. Ribosomal protein L30 is a
component of the UGA-selenocysteine recoding machinery in eu-
karyotes. Nat Struct Mol Biol 12: 408–416.
Cléry A, Bourguignon-Igel V, Allmang C, Krol A, Branlant C. 2007. An
improved definition of the RNA-binding specificity of SECIS-bind-
ing protein 2, an essential component of the selenocysteine incorpo-
ration machinery. Nucleic Acids Res 35: 1868–1884.
Copeland PR, Driscoll DM. 1999. Purification, redox sensitivity,
and RNA binding properties of SECIS-binding protein 2, a protein
involved in selenoprotein biosynthesis. J Biol Chem 274: 25447–
25454.
Copeland PR, Driscoll DM. 2002. Purification and analysis of selenocys-
teine insertion sequence-binding protein 2. Methods Enzymol 347:
40–49.
Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, Driscoll DM. 2000.
A novel RNA binding protein, SBP2, is required for the translation of
mammalian selenoprotein mRNAs. EMBO J 19: 306–314.
Copeland PR, Stepanik VA, Driscoll DM. 2001. Insight into mammalian
selenocysteine insertion: Domain structure and ribosome binding
properties of Sec insertion sequence binding protein 2. Mol Cell
Biol 21: 1491–1498.
Dmitriev S, Pisarev A, Rubtsova M, Dunaevsky Y, Shatsky I. 2003.
Conversion of 48S translation preinitiation complexes into 80S ini-
tiation complexes as revealed by toeprinting. FEBS Let 533: 99–104.
Donovan J, Caban K, Ranaweera R, Gonzalez-Flores JN, Copeland PR.
2008. A novel protein domain induces high affinity selenocysteine
insertion sequence binding and elongation factor recruitment. J
Biol Chem 283: 35129–35139.
Dubreuil YL, Expert-Bezançon A, Favre A. 1991. Conformation and
structural fluctuations of a 218 nucleotides long rRNA fragment:
4-thiouridine as an intrinsic photolabelling probe. Nucleic Acids
Res 19: 3653–3660.
Fagegaltier D, Hubert N, Yamada K, Mizutani T, Carbon P, Krol A.
2000a. Characterization of mSelB, a novel mammalian elongation
factor for selenoprotein translation. EMBO J 19: 4796–4805.
Fagegaltier D, Lescure A, Walczak R, Carbon P, Krol A. 2000b.
Structural analysis of new local features in SECIS RNA hairpins.
Nucleic Acids Res 28: 2679–2689.
Fletcher J, Copeland P, Driscoll D, Krol A. 2001. The selenocysteine in-
corporation machinery: Interactions between the SECIS RNA and
the SECIS-binding protein SBP2. RNA 10: 1442–1453.
Gonzalez-Flores JN, Gupta N, DeMong LW, Copeland PR. 2012. The
selenocysteine-specific elongation factor contains a novel and mul-
ti-functional domain. J Biol Chem 287: 38936–38945.
Graifer DM, Karpova GG. 2012. Structural and functional topography
of human ribosome. Acta Biochim Biophys Sin 44: 281–299.
Graifer D, Molotkov M, Styazhkina V, Demeshkina N, Bulygin K,
Eremina A, Ivanov A, Laletina E, Ven’yaminova A, Karpova G.
2004. Variable and conserved elements of human ribosomes sur-
rounding the mRNA at the decoding and upstream sites. Nucleic
Acids Res 32: 3282–3293.
Jimenez A, Carrasco L, Vazquez D. 1977. Enzymic and nonenzymic
translocation by yeast polysomes. Site of action of a number of inhib-
itors. Biochemistry 16: 4727–4730.
Kozak M. 1998. Primer extension analysis of eukaryotic ribosome-
mRNA complexes. Nucleic Acids Res 26: 4853–4859.
Laletina E, Graifer D, Malygin A, Ivanov A, Shatsky I, Karpova G. 2006.
Proteins surrounding hairpin IIIe of the hepatitis C virus internal ri-
bosome entry site on the human 40S ribosomal subunit. Nucleic
Acids Res 34: 2027–2036.
A mechanism for selenocysteine insertion
www.rnajournal.org 11
 Cold Spring Harbor Laboratory Press on June 12, 2017 - Published by rnajournal.cshlp.orgDownloaded from 
Lapidot Y, de Groot N. 1972. The chemical synthesis and biochemical
properties of peptidyl-tRNA. ProgNucleic Acid Res Mol Biol 12:
189–225.
Lescure A, Allmang C, Yamada K, Carbon P, Krol A. 2002. cDNA clon-
ing, expression pattern and RNA binding analysis of human seleno-
cysteine insertion sequence (SECIS) binding protein 2. Gene 291:
279–285.
Lescure A, Rederstorff M, Krol A, Guicheney P, Allamand V. 2009.
Selenoprotein function and muscle disease. Biochem Biophys Acta
90: 1569–1574.
Miniard AC, Middleton LM, Budiman ME, Gerber CA, Driscoll DM.
2010. Nucleolin binds to a subset of selenoprotein mRNAs and reg-
ulates their expression. Nucleic Acids Res 38: 4807–4820.
Papp LV, Lu J, Striebel F, Kennedy D, Holgrem A, Khanna KK.
2006. The redox state of SECIS binding protein 2 controls its local-
ization and selenocysteine incorporation function. Mol Cell Biol 26:
4895–4910.
Papp LV, Lu J, Holgrem A, Khanna KK. 2007. From selenium to seleno-
proteins: Synthesis, identity, and their role in human health.
Antioxid Redox Signal 9: 775–806.
Pisarev AV, Kolupaeva VG, Yusupov MM, Hellen CUT, Pestova TV.
2008. Ribosomal position and contacts of mRNA in eukaryotic
translation initiation complexes. EMBO J 27: 1609–1621.
Roessler JR, Xu C, Payne RC, Surratt CK, Hecht SM. 1989. Preparation
of the misacylated aminoacyl-tRNA(Phe)’s useful as probes of the ri-
bosomal acceptor site. Biochemistry 28: 5185–5195.
Schofield P, Zamecnik P. 1968. Cupric ion catalysis in hydrolysis of ami-
noacyl-tRNA. Biochim Biophys Acta 155: 410–416.
Stoytcheva JZ, Tujebajeva RM, Harney JW, Berry MJ. 2006. Efficient
incorporation of multiple selenocysteines involves an inefficient
decoding step serving as a potential translational checkpoint and
ribosome bottleneck. Mol Cell Biol 26: 9177–9184.
Sturchler C, Hubert N, Totsuka T, Mizutani T, Carbon P, Krol A. 1995.
Selenocysteylation in eukaryotes necessitates the uniquely long ami-
noacyl acceptor stem of selenocysteine tRNASec. J Biol Chem 270:
18570–18574.
Takeuchi A, Schmitt D, Chapple C, Babaylova E, Karpova G, Guigo R,
Krol A, Allmang C. 2009. A short motif inDrosophila SECIS Binding
Protein 2 provides differential binding affinity to SECIS RNA hair-
pins. Nucleic Acids Res 37: 2126–2141.
Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Harney
JW, Driscoll DM, Hatfield DL, Berry MJ. 2000. Decoding ap-
paratus for eukaryotic selenocysteine insertion. EMBO Rep 1: 158–
163.
Walczak R, Westhof E, Carbon P, Krol A. 1996. A novel RNA structural
motif in selenocysteine insertion element of eukaryotic selenopro-
tein mRNAs. RNA 2: 367–379.
Walczak R, Carbon P, Krol A. 1998. An essential non-Watson–Crick
base pair motif in 3′UTR to mediate selenoprotein translation.
RNA 4: 74–84.
Zhang Y, Gladyshev VN. 2011. Comparative genomics of trace element
dependence in biology. J Biol Chem 286: 23623–23629.
Kossinova et al.
12 RNA, Vol. 19, No. 8
 Cold Spring Harbor Laboratory Press on June 12, 2017 - Published by rnajournal.cshlp.orgDownloaded from 
 published online June 20, 2013RNA
  
Olga Kossinova, Alexey Malygin, Alain Krol, et al. 
  
synthesis
A novel insight into the mechanism of mammalian selenoprotein
  
P<P
  
Published online June 20, 2013 in advance of the print journal.
  
License
Commons 
Creative
.http://creativecommons.org/licenses/by-nc/3.0/3.0 Unported), as described at 
months, it is available under a Creative Commons License (Attribution-NonCommercial 
). After 12http://rnajournal.cshlp.org/site/misc/terms.xhtmlfull-issue publication date (see 
This article is distributed exclusively by the RNA Society for the first 12 months after the
Service
Email Alerting
  
 click here.right corner of the article or 
Receive free email alerts when new articles cite this article - sign up in the box at the top
 http://rnajournal.cshlp.org/subscriptions
 go to: RNATo subscribe to 
© 2013; Published by Cold Spring Harbor Laboratory Press for the RNA Society
 Cold Spring Harbor Laboratory Press on June 12, 2017 - Published by rnajournal.cshlp.orgDownloaded from 
